lcp
We have detected you are using Internet Explorer. To provide the best and most secure experience, please use a modern browser as we do not support Internet Explorer.

Total Intravenous Anaesthesia (TIVA)

17 August 2021 - Crystal Smith

TIVA is one way of achieving this, as the avoidance of volatile agents during general anaesthesia is associated with a more rapid emergence and less side effects. TIVA may be achieved with a single agent such as propofol for shorter procedures, or can be combined with other agents.

Factors Influencing TIVA Medication Combinations

The specific combination of medications to achieve TIVA will be dependent on many factors, and should take into account individual patient needs including surgical requirements to reflect the individual needs of patients and the planned surgical procedure. A sufficient plane of anaesthesia can be achieved through either continuous infusion or bolus dosing, depending on the length of the procedure to be performed.

Advantages of TIVA over Volatile Agents

In comparison to inhaled volatile agents, TIVA has the advantages of:

  • Significantly less postoperative nausea and vomiting (PONV) with the use of propofol
  • Faster emergence from anaesthesia
  • Significant reduction of emergence delirium in paediatric patients
  • Reduction of cognitive impairment and delirium in elderly patients
  • Reduced airway irritation in all ages, including post extubation cough
  • Half the risk of laryngospasm and bronchospasm in paediatric patients
  • Maintenance of cardiac functioning, especially notable in elderly patients who are able to maintain lung perfusion and have less cardiac depression
  • Suitable for use in patients with a potential/confirmed risk of malignant hyperthermia

Clinical Benefits of TIVA with Propofol

These benefits of TIVA, particularly with the utilisation of propofol, have enhanced the options available for general anaesthesia. Patients who are undergoing short procedures or investigations as day only patients are often able to be discharged home faster, as the side effects are reduced. 

Further Learning

If you would like to learn more about pharmacological considerations in the perioperative environment, join us for one of the following courses:

 

References:

Chokshi, T., Channabasappa, S., Vergheese, D. C., Bajwa, S., Gupta, B., & Mehdiratta, L. (2020). Re-emergence of TIVA in COVID times. Indian journal of anaesthesia, 64(Suppl 2), S125–S131. https://doi.org/10.4103/ija.IJA_554_20.

 

Jin, Z., Gan, T. J., & Bergese, S. D. (2020). Prevention and Treatment of Postoperative Nausea and Vomiting (PONV): A Review of Current Recommendations and Emerging Therapies. Therapeutics and clinical risk management, 16, 1305–1317. https://doi.org/10.2147/TCRM.S256234.

 

Miller D, Lewis SR, Pritchard MW, Schofield-Robinson OJ, Shelton CL, Alderson P, Smith AF. (2018). Intravenous versus inhalational maintenance of anaesthesia for postoperative cognitive outcomes in elderly people undergoing non-cardiac surgery. Cochrane Database Syst Rev. Aug 21; 8(8):CD012317. doi: 10.1002/14651858.CD012317.pub2. PMID: 30129968; PMCID: PMC6513211.

 

Nimmo, A.F., Absalom, A.R., Bagshaw, O., Biswas, A., Cook, T.M., Costello, A., Grimes, S., Mulvey, D., Shinde, S., Whitehouse, T. and Wiles, M.D. (2019), Guidelines for the safe practice of total intravenous anaesthesia (TIVA). Anaesthesia, 74: 211-224. doi.org/10.1111/anae.14428. 

 

Stephenson, S. J., Jiwanmall, M., Cherian, N. E., Kamakshi, S., & Williams, A. (2021). Reduction in post-operative nausea and vomiting (PONV) by preoperative risk stratification and adherence to a standardized anti emetic prophylaxis protocol in the day-care surgical population. Journal of family medicine and primary care, 10(2), 865–870. https://doi.org/10.4103/jfmpc.jfmpc_1692_20.


Wong, S., Choi, S. W., Lee, Y., Irwin, M. G., & Cheung, C. W. (2018). The analgesic effects of intraoperative total intravenous anesthesia (TIVA) with propofol versus sevoflurane after colorectal surgery. Medicine, 97(31), e11615. https://doi.org/10.1097/MD.0000000000011615.

SHARE:
Crystal Smith
Crystal Smith

Crystal Smith is a Senior Education Consultant for Critical Care Education Services (part of the Medcast Group). She has a clinical background in critical care, paediatrics and education.

Get Medcast Plus

Become a member and get unlimited access to 100s of hours of premium education.

Learn more
Latest News
The ABCDE of post resuscitation care

Following 10 minutes of CPR and two shocks for VT, Nadia shows signs of life. After the third rhythm check, with respiratory effort noted, the defib was disarmed using the COACHED sequence. What is the next step in determining the plan of care for Nadia?

5 mins READ
PODCAST: Addressing disease burden, risk factors and health behaviours in Australian males aged 18-44

Men’s Health Week is June 10 -16 2024. Listen in to this podcast to learn about what is impacting the health and wellbeing of Australian men and how we can support males to adopt healthy behaviours.

35 mins READ
Does Hafiz need a referral for allergy testing?

Hafiz, a 13-month-old, developed a rash and swelling around their mouth after eating peanut butter, displaying signs of a potential IgE-mediated food allergy. What are the next steps for Hafiz?

5 mins READ